Pharma news

Reset all filters
Geography
Company
Refine search
Novartis and MSN feud intensifies after Fed Circ denies rehearing
Americas
Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent should be delisted from the Orange Book | Novartis urges injunction to block generic version of heart treatment before regulatory gap closes.   27 March 2025
EU court signals tough stance on ‘pay-for-delay’ pharma deals
Europe
Advocate general recommends upholding €60.48 million fine against Teva and Cephalon for anti-competitive modafinil settlement.   27 March 2025
Trouble at the USPTO—Part II: Bracing for impact
Americas
As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen.   13 March 2025
Americas
Return-to-office orders, redundancies, hiring freezes—do changes sweeping through the US agency ‘risk breaking the system’? Marisa Woutersen finds patent practitioners fearful of the future.   6 March 2025
Pharma
Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva temporarily paused in January pending the appeal court’s decision to review.   4 March 2025
Europe
Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona Silverman of Freeths.   27 February 2025
Americas
Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler.   25 February 2025
Americas
Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.   20 February 2025
Americas
Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.   6 February 2025
Europe
UK court confirms it cannot depart from CJEU law | SPC application for multiple sclerosis treatment rejected | Judges stress that any change to the SPC framework needs legislative reform not interpretation.   30 January 2025